NCT04748523View on ClinicalTrials.gov

Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 29, 2018

Primary Completion Date

July 29, 2022

Study Completion Date

October 29, 2022

Conditions
AnorexiaNon-small Cell Lung Cancer
Interventions
DRUG

Mirtazapine

arm to receive 15 to 30 mg of Mirtazapine for a period of 8 weeks.

DRUG

Placebo Oral Tablet

arm to receive 15 to 30 mg of Placebo for a period of 8 weeks.

Trial Locations (1)

14080

Instituto Nacional de Cancerologia, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Cancerologia de Mexico

OTHER

NCT04748523 - Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia | Biotech Hunter | Biotech Hunter